KuoOffice's videos (36)


852
May 26, 2010
Module II - Section 4

Key Therapeutic Area: Neurology http://pharmacogenomics.ucsd.edu/

1093
May 26, 2010
Module II - Section 3

Key Therapeutic Area: Anticoaugulation http://pharmacogenomics.ucsd.edu/

868
May 26, 2010
Module II - Section 2

Key Therapeutic Area: Oncology http://pharmacogenomics.ucsd.edu/

927
May 26, 2010
Module II - Section 1

Key Therapeutic Area: Infectious Disease http://pharmacogenomics.ucsd.edu/

904
May 26, 2010
Module I - Section 5

Ethical Legal Social Issues http://pharmacogenomics.ucsd.edu/

812
May 26, 2010
Module I - Section 4

Patient Case 2 http://pharmacogenomics.ucsd.edu/

942
May 26, 2010
Module I - Section 3

Patient Case 1 http://pharmacogenomics.ucsd.edu/

904
May 26, 2010
Module I - Section 2

Pharmacogenomic Nomenclature

840
May 26, 2010
Module I - Section 1

Translating Pharmacogenomic Into Practice http://pharmacogenomics.ucsd.edu/

1772
Apr 21, 2010
A variant of the HTRA1 gene increases susceptibility to age-related macular...

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world...

770
Apr 14, 2010
Evaluation of an Educational Program for Women and Pharmacists on Safe Use of...

To increase the awareness of CTIS services for pharmacists and consumers

1643
Feb 16, 2010
Dr. Beatriz Lewis's Pharmacy Practice at UCSD's Moores Cancer Center

The San Diego Pharmacist Resource and Research Network is conducting a study to discover the best...

9177
Nov 23, 2009
PharmGenEd™ Principles and Concepts of Pharmacogenomics

The presentation is divided into several sections as outlined by the powerpoint slide. In this module we will...

3912
Nov 18, 2009
PharmGenEd: Clinical Application of Pharmacogenomics

We will review the use of pharmacogenomic tests in five therapeutic areas. Infectious disease Oncology...